Subscribe To Our Free Newsletter |
Pricing challenge in US biz, rich valuations may weigh on pharma stocks
Among individual players, Aurobindo Pharma, Dr Reddys Labs, and Zydus Lifesciences sourced 48 per cent, 47 per cent, and 46 per cent of their total revenues from the US generics segment, respectively